Supplementary Online Content

Size: px
Start display at page:

Download "Supplementary Online Content"

Transcription

1 Supplementary Online Content Sjöström L, Peltonen M, Jacobson P, et al. Association bariatric surgery with long-term remission type 2 diabetes and with microvascular and macrovascular complications. JAMA. doi: /jama eappendix 1. SOS study design and recruitment efigure 1. SOS: Weight changes over 15 years in the control and surgery groups with diabetes at baseline efigure 2. SOS: Prevalence diabetes remission in controls and the three bariatric surgery subgroups after 2, 10 and 15 years follow up efigure 3. SOS: The cumulative incidence all (microvascular plus macrovascular) diabetes complications in the three surgery groups etable 1. SOS: Nonfatal and fatal diabetes complications according to ICD-9 and ICD-10 and according to Surgical procedures as coded in the National Swedish Patient Register (with inpatient and specialist outpatient care) and Cause Death Register etable 2. Baseline characteristics, weight change by treatment group and participation status at 15-year follow-up etable 3. SOS: Multivariable logistic regression model on diabetes remission at 2 years for surgery and control groups combined etable 4. SOS: Association between bariatric surgery and diabetes remission without and with multiple imputations etable 5. SOS: Multivariable logistic regression models on diabetes remission and relapse in the surgery groups etable 6. Cox proportional hazard regression models treatment and baseline variables on (A) microvascular and (B) macrovascular diabetes complications during up to 25 years This supplementary material has been provided by the authors to give readers additional information about their work.

2 2 eappendix: SOS study design and recruitment After recruitment campaigns in mass media and at primary health care centers, a matching examination was completed by 6905 patients. Among 5335 eligible individuals, 2010 choosing surgery formed the surgery group. A contemporaneously matched control group 2037 individuals was created using 18 matching variables. The matching variables were sex, age, weight, height, waist and hip circumferences, systolic blood pressure, serum cholesterol and triglyceride levels, smoking status, diabetes, menopausal status and four psychosocial variables with documented associations with the risk death [social support, life events, health perception, psychosocial functioning], and two personality traits related to treatment preferences [monotony avoidance, psychastenia] (Karlsson J, Sjöström L & Sullivan M. J Clin Epidemiol, vol 48: , 1995). According to the method sequential treatment assignment, a matching algorithm selected controls so that the current mean values the matching variables in the control group became as similar as possible to the current mean values in the surgery group (Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975;31: ) The two study groups had identical inclusion and exclusion criteria, and all controls were eligible for surgery. The inclusion criteria were aged 37 to 60 years and BMI 34 kg/m2 or more for men and 38 kg/m2 or more for women before or at the matching examination. The exclusion criteria were earlier surgery for gastric or duodenal ulcer, earlier bariatric surgery, gastric ulcer during the past 6 months, ongoing malignancy, active malignancy during the past 5 years, myocardial infarction during the past 6 months, bulimic eating pattern, drug or alcohol abuse, psychiatric or cooperative problems contraindicating bariatric surgery, other contraindicating conditions (such as chronic glucocorticoid or anti-inflammatory treatment). To examine the association between bariatric surgery and diabetes remission and incidence diabetes complications, 603 patients who had diabetes at baseline were included in the analysis.

3 3 SUPPLEMENTARY FIGURES AND TABLES efigure 1. SOS: Weight changes over 15 years in the control and surgery groups with diabetes at baseline. Bars represent 95% confidence intervals. VBG, vertical banded gastroplasty. GBP, gastric bypass.

4 4 efigure 2. SOS: Prevalence diabetes remission in controls and the three bariatric surgery subgroups after 2, 10 and 15 years follow up. Diabetes remission was defined as fasting blood glucose levels lower than 110 mg per deciliter and no diabetes medication. 95 percent confidence intervals are indicated. VBG, vertical banded gastroplasty. GBP, gastric bypass. Panel A: Patients were analyzed according to their original treatment allocation. Panel B: Controls who have later obtained surgery and surgery patients who have later been converted to another surgical method were excluded.

5 5 efigure 3. SOS: The cumulative incidence all (microvascular plus macrovascular) diabetes complications in the three surgery groups. Surgery patients who had been converted to another surgical method after the initial operation at baseline were removed from calculations. Diabetes complications requiring hospital treatment, specialist care or diabetes complications that were associated with death during follow-up were traced by cross-checking against the Swedish National Patient Register (consisting inpatient and specialist outpatient registers) and the Cause Death Registry until December 31, The ICD codes and surgery procedures used for cross checking are specified in S-Table 1. The x-axis is truncated at 20 years, but all observations after 20 years were included in the statistical analysis. VBG, vertical banded gastroplasty. GBP, gastric bypass.

6 6 etable 1. SOS. Nonfatal and fatal diabetes complications according to ICD-9 and ICD-10 and according to Surgical procedures as coded in the Patient Register (with inpatient and specialist outpatient care) and Cause Death Register. Registry searches were performed using these codes and any sub-classifications there. Diagnosis ICD-9 ICD-10 Surgical procedures Procedure codes operations,! Ed. 5, 1985 Ed. 6, 1989, both editions including also Procedure codes surgical procedures (KKÅ) 1997 Temporary list procedures (TÅL) Microvascular diabetes complications, non-fatal or fatal Kidney complications 250D E11.2 E10.2* E14.2 Swedish Classifications Health Interventions (KVÅ) 2007 # including both surgical (KKÅ) and (KMÅ) Kidney transplantation 6070 KAS00 KAS10 KAS20

7 7 Diagnosis ICD-9 ICD-10 Surgical procedures Procedure codes operations,! Ed. 5, 1985 Ed. 6, 1989, both editions including also Procedure codes surgical procedures (KKÅ) 1997 Temporary list procedures (TÅL) Diabetes nephropathy N08.3 Kidney biopsy Swedish Classifications Health Interventions (KVÅ) 2007 # including both surgical (KKÅ) and (KMÅ) KAB00 KAB01 Albuminuria Renal failure Dialysis 791A 584 to 586 V45B R80 N39.1 N17 to N19 Z99.2 Hemodialysis Peritoneal dialysis DR015 DR016 DR020 V9211 V9212 DR023 DR024

8 8 Diagnosis ICD-9 ICD-10 Surgical procedures Procedure codes operations,! Ed. 5, 1985 Ed. 6, 1989, both editions including also Procedure codes surgical procedures (KKÅ) 1997 Temporary list procedures (TÅL) Eye complications V56A V56W 250E Z49 E11.3 E10.3* E14.3 Swedish Classifications Health Interventions (KVÅ) 2007 # including both surgical (KKÅ) and (KMÅ) JAK10 TJA20 TJA33 V9213 V9214 Diabetes retinopathy 250E H36.0 Retinal operations CKC

9 9 Diagnosis ICD-9 ICD-10 Surgical procedures Procedure codes operations,! Ed. 5, 1985 Ed. 6, 1989, both editions including also Procedure codes surgical procedures (KKÅ) 1997 Temporary list procedures (TÅL) Neurological complications Amyotrophy Autonomous (poly)neuropathy Mononeuropathy Polyneuropathy Peripheral, mainly macrovascular diabetes complications, non-fatal and fatal + 250F 357E E11.4 E10.4* E14.4 G73.0 G99.0 G59.0 G63.2 Swedish Classifications Health Interventions (KVÅ) 2007 # including both surgical (KKÅ) and (KMÅ) CKD

10 10 Diagnosis ICD-9 ICD-10 Surgical procedures Procedure codes operations,! Ed. 5, 1985 Ed. 6, 1989, both editions including also Procedure codes surgical procedures (KKÅ) 1997 Temporary list procedures (TÅL) Claudication, atherosclerosis arteries extremities Diabetes gangrene, diabetic foot Diabetes gangrene, cont. 443X 440C 250G I70.2 E11.5 E10.5* E14.4 I79.2 Amputations on leg or foot Operations on suprarenal aorta and visceral arteries Swedish Classifications Health Interventions (KVÅ) 2007 # including both surgical (KKÅ) and (KMÅ) NFQ NGQ NHQ PCE PCF PCG PCH

11 11 Diagnosis ICD-9 ICD-10 Surgical procedures Procedure codes operations,! Ed. 5, 1985 Ed. 6, 1989, both editions including also Procedure codes surgical procedures (KKÅ) 1997 Temporary list procedures (TÅL) Operations on renal aorta and iliac arteries Swedish Classifications Health Interventions (KVÅ) 2007 # including both surgical (KKÅ) and (KMÅ) PCJ PCK PCN PCP PCQ PDE PDF PDG PDH PDN

12 12 Diagnosis ICD-9 ICD-10 Surgical procedures Procedure codes operations,! Ed. 5, 1985 Ed. 6, 1989, both editions including also Procedure codes surgical procedures (KKÅ) 1997 Temporary list procedures (TÅL) Swedish Classifications Health Interventions (KVÅ) 2007 # including both surgical (KKÅ) and (KMÅ) PDP PDQ PDS Operations leg arteries PEE PEF PEG PEH PEN

13 13 Diagnosis ICD-9 ICD-10 Surgical procedures Procedure codes operations,! Ed. 5, 1985 Ed. 6, 1989, both editions including also Procedure codes surgical procedures (KKÅ) 1997 Temporary list procedures (TÅL) Macrovascular centrally located diabetes complications, non-fatal or fatal Swedish Classifications Health Interventions (KVÅ) 2007 # including both surgical (KKÅ) and (KMÅ) PEP PEQ PFE PFG PFH PFN PFP PFQ PFS

14 14 Diagnosis ICD-9 ICD-10 Surgical procedures Procedure codes operations,! Ed. 5, 1985 Ed. 6, 1989, both editions including also Procedure codes surgical procedures (KKÅ) 1997 Temporary list procedures (TÅL) Angina pectoris Acute myocardial infarction Myocardial reinfarction Complications to myocardial inf. Other ischemic conditions I20 I21 I22 I23 I24 I25 Coronary artery operations Heart transplantation Swedish Classifications Health Interventions (KVÅ) 2007 # including both surgical (KKÅ) and (KMÅ) FNA to FNK FNW FQA FQB Heart failure 428 I50 Subarachnoidal bleeding 430 I60 Aneurysm operations AAC AAL

15 15 Diagnosis ICD-9 ICD-10 Surgical procedures Procedure codes operations,! Ed. 5, 1985 Ed. 6, 1989, both editions including also Procedure codes surgical procedures (KKÅ) 1997 Temporary list procedures (TÅL) Hemorrhagia cerebri Cerebral infarction Unspecified stroke x I61 I62 I63 I64 Swedish Classifications Health Interventions (KVÅ) 2007 # including both surgical (KKÅ) and (KMÅ) Arterial operations 0193 PAF PAG PAH PAJ PAK! First edition Operations (Swedish: Klassifikation av Operationer) was printed by the and Welfare in 1963.

16 16 # KVÅ is available only on the net ( and is updated annually since Older code lists were printed by the and Welfare. * In the Swedish National Patient Registry and the Cause Death Registry, complications some typical type 2 diabetic individuals have erroneously been coded as type 1 diabetes (i.e. with E10# codes), particularly if they have obtained insulin treatment. Since we know that all patients in this report had type 2 diabetes at baseline (see Methods), we have included both E11 (type 2) and E10 (type 1) codes in our searches for complications type 2 diabetes. + Since we know that all patients in this report had type 2 diabetes at the SOS baseline examination, we have considered claudication as well as heart and brain problems as diabetic complications even if diabetes is not a specified diagnosis in the corresponding hospital records.

17 17 etable 2. Baseline characteristics, weight change by treatment group and participation status at 15-year follow-up. Individuals with diabetes at baseline in the SOS study. Non-participants: did not participate at 15-year follow-up; Participants: did participate at 15-year follow-up. SURGERY Non-participants at 15 year, n=172 Participants at 15 year, n=115 Baseline data: Mean SD Mean SD t- or z-value CONTROL Non-participants at 15 year, n=135 Participants at 15 year, n=62 p- value Mean SD Mean SD Sex, men (%) 71 (41.3) 50 (43.5) (37.0) 32 (51.6) -1.9 Age, yr Weight, kg BMI, kg/m Waist, cm Hip, cm Waist-hip ratio Blood glucose, mg/dl Serum insulin, mu/l HOMA-IR Systolic blood pressure, mmhg Diast blood pressure, mmhg Total cholesterol, mg/dl HDL cholesterol, mg/dl t- or z- value p- valu e

18 18 SURGERY Non-participants at 15 year, n=172 Participants at 15 year, n=115 CONTROL Non-participants at 15 year, n=135 Participants at 15 year, n=62 Triglycerides, mg/dl U-albumin excretion, μg/minute, median IQR* ( ) ( ) ( ) ( ) Smoking, n (%) 44 (25.7) 26 (22.6) (26.5) 9 (14.5) 1.8 Physically active, leisure time, n (%) 84 (49.1) 64 (55.7) (61.1) 44 (71.0) -1.3 Total calorie intake, kcal Weight change at 2-year, kg % CI (-25.8 to -21.6) (-30.4 to -24.6) (-4.6 to -1.5) (-6.8 to -1.7) Weight change at 10 yr, kg % CI (-23.6 to -17.5) (-26.1 to -20.1) (-7.0 to 0.3) (-8.5 to -2.5) * IQR: Interquartile range.

19 19 etable 3. SOS: Multivariable logistic regression model on diabetes remission at 2 years for surgery and control groups combined. Surgery plus Control group Remission n=253/n=510 Baseline variables Remission from diabetes at 2 years Multiple imputation analysis # OR 95% CI z p OR 95% CI t p Surgery, yes (219/303) vs. no (34/207) < <0.001 Sex, men (101/201) vs women (152/309) Age, per 6.2 years Blood glucose, per 48 mg/dl <0.001 BMI, per 4.8 kg/m Diabetes duration, per 4.6 years < Oral antidiab. medication, yes (67/195) vs. no (177/255) 0.19 Insulin treatment, yes (9/60) vs. no (177/255) < < Odds-ratios (OR) are expressed as surgery v.s. control, men v.s. women etc. for dichotomous variables, and per standard deviation increase for continuous variables. OR values greater than 1 indicate higher likelihood for the occurrence outcome. Men coded as 1, women as 0. Yes coded as 1, no as 0. # Multiple Imputation calculations are based on observed plus imputed data. The missing outcome data were imputed using chained equations with Stata (version 12.1). The following variables were used as predictors missing outcome data: age, sex, treatment group (surgery/control), body mass index at baseline, and blood glucose at baseline. The number imputations (complete datasets with imputed values) was set to 30.

20 20 etable 4. SOS: Association between bariatric surgery and diabetes remission without and with multiple imputations. Observation year Participation rate (adjusted for mortality) Number observations Odds Ratio Surg Contr Surg Contr OR 95% CI P Observed data (no imputations) Baseline years < years < years <0.001 Multiple imputation # 2 years < years < years <0.001 Odds-ratios (OR) are expressed as surgery vs control ; values greater than 1 indicate higher likelihood for remission in the surgery group as compared to control group. # Multiple Imputation calculations are based on observed plus imputed data. The missing outcome data were imputed using chained equations with Stata (version 12.1). The following variables were used as predictors missing outcome data: age, sex, treatment group (surgery/control), body mass index at baseline, and all observed data on blood glucose at baseline and during follow-up. The number imputations (complete datasets with imputed values) was set to 30.

21 21 etable 5. SOS: Multivariable logistic regression models on diabetes remission and relapse in the surgery group. Odds ratios (OR) for continuous variables are expressed per standard deviation. All variables except weight change 0-2 years refer to baseline conditions. For direction relationships, see foot note. A. Remission from diabetes at 2 years in the surgery group. B. Two to ten-year relapse after remission at 2 years in the surgery group. A. Surgery group only. Remission from type 2 diabetes at 2 years Remission n=84/n=303 Observed data Observed plus imputed data OR# 95% CI z p OR# 95% CI z p Sex, men (88/120) vs. women (131/183) Age, per 6.2 years Blood glucose, per 48 mg/dl BMI, per 4.8 kg/m Diabetes duration, per 4.6 years < Oral antidiab. medication, Yes (66/111) vs. no (145/156) < Insulin treatment, Yes (8/36) vs. no (145/156) B. Surgery group only. 10-year relapse after 2-year remission from diabetes Relapse n=88/n=169 Observed data Observed plus imputed data OR# 95% CI z p OR# 95% CI z p Sex, men (45/70) vs. women (43/99) Age, per 6.2 years Blood glucose, per 48 mg/dl BMI, per 4.8 kg/m Diabetes duration, per 4.6 years Weight change 0 to 2 yrs, per 16.9 kg < <0.001 # Odds-ratios (OR) are expressed as men vs women etc. for dichotomous variables, and per standard deviation increase for continuous variables. OR values greater than 1 indicate higher likelihood for the occurrence outcome (remission and relapse, respectively). Men coded as 1, women as 0. Yes coded as 1, no as 0. Multiple Imputation calculations are based on observed plus imputed data. The missing outcome data were imputed using chained equations with Stata (version 12.1). The following variables were used as predictors missing outcome data: age, sex, treatment group (surgery/control), body mass index at baseline, and all observed data on blood glucose at baseline and during follow-up. The number imputations (complete datasets with imputed values) was set to 30.

22 etable 6. Cox proportional hazard regression models treatment and baseline variables on (A) microvascular and (B) macrovascular diabetes complications during up to 25 years. Hazard ratios (HR) for continuous variables are expressed per standard deviation. The ICD codes and surgery procedures used for cross checking against the Swedish National Inpatient, Specialist Outpatient and Cause Death registries are specified in etable 1. A. Surgery and control groups: Microvascular complications 240 events/ N=603. HR# 95% CI z p Surgery (106/343), vs. control (134/260) <0.001 Sex, men (108/245) vs. women (132/358) Age, per 6.2 years Blood glucose, per 48 mg/dl <0.001 BMI, per 4.8 kg/m Diabetes duration, per 4.6 years <0.001 B. Surgery and control groups: Macrovascular complications 293 events/n=603. HR# 95% CI z p Surgery (151/343) vs. control (142/260) Sex, men (146/245) vs. women (147/358) <0.001 Age, per 6.2 years <0.001 Blood glucose, per 48 mg/dl BMI, per 4.8 kg/m Diabetes duration, per 4.6 years < # Hazard-ratios (HR) are expressed as surgery vs. control, men vs women etc. for dichotomous variables, and per standard deviation increase for continuous variables. HR values greater than 1 indicate higher likelihood for the occurrence diabetes complications. Men coded as 1, women as 0. Yes coded as 1, no as 0.

ESPEN Congress Florence 2008

ESPEN Congress Florence 2008 ESPEN Congress Florence 2008 Severe obesity - Session organised in conjunction with ASPEN The SOS study Setting the Scene A. Thorell (Sweden) The SOS study Setting the Scene Anders Thorell MD, PhD Associate

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Rawshani Aidin, Rawshani Araz, Franzén S, et al. Risk factors,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.

More information

Supplementary Online Content. Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and

Supplementary Online Content. Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and 1 Supplementary Online Content 2 3 4 5 6 Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and cardiometabolic risk factor management on sympton burden and severity in patients with atrial

More information

ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study

ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study Statistical modelling details We used Cox proportional-hazards

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter

More information

Bariatric Surgery versus Intensive Medical Therapy for Diabetes 3-Year Outcomes

Bariatric Surgery versus Intensive Medical Therapy for Diabetes 3-Year Outcomes The new england journal of medicine original article Bariatric Surgery versus Intensive Medical for Diabetes 3-Year Outcomes Philip R. Schauer, M.D., Deepak L. Bhatt, M.D., M.P.H., John P. Kirwan, Ph.D.,

More information

Supplement materials:

Supplement materials: Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Åsvold BO, Vatten LJ, Bjøro T, et al; Thyroid Studies Collaboration. Thyroid function within the normal range and risk of coronary heart disease: an individual participant

More information

Table S1. Read and ICD 10 diagnosis codes for polymyalgia rheumatica and giant cell arteritis

Table S1. Read and ICD 10 diagnosis codes for polymyalgia rheumatica and giant cell arteritis SUPPLEMENTARY MATERIAL TEXT Text S1. Multiple imputation TABLES Table S1. Read and ICD 10 diagnosis codes for polymyalgia rheumatica and giant cell arteritis Table S2. List of drugs included as immunosuppressant

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Wolters FJ, Li L, Gutnikov SA, Mehta Z, Rothwell PM. Medical attention seeking after transient ischemic attack and minor stroke in relation to the UK Face, Arm, Speech, Time

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and

More information

ADVANCE post trial ObservatioNal Study

ADVANCE post trial ObservatioNal Study Hot Topics in Diabetes 50 th EASD, Vienna 2014 ADVANCE post trial ObservatioNal Study Sophia Zoungas The George Institute The University of Sydney Rationale and Study Design Sophia Zoungas The George Institute

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Afkarian M, Zelnick L, Hall YN, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA. doi:10.1001/jama.2016.10924 emethods efigure

More information

Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use

Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use Baseline characteristics Users (n = 28) Non-users (n = 32) P value Age (years) 67.8 (9.4) 68.4 (8.5)

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content McEvoy JW, Chen Y, Ndumele CE, et al. Six-year change in high-sensitivity cardiac troponin T and risk of subsequent coronary heart disease, heart failure, and death. JAMA Cardiol.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553-1559. eequation. Applying the

More information

egfr > 50 (n = 13,916)

egfr > 50 (n = 13,916) Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according

More information

A factorial randomized trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

A factorial randomized trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes A factorial randomized trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Hypotheses: Among individuals with type 2 diabetes, the risks of major microvascular

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Dharmarajan K, Wang Y, Lin Z, et al. Association of changing hospital readmission rates with mortality rates after hospital discharge. JAMA. doi:10.1001/jama.2017.8444 etable

More information

Supplementary Online Content

Supplementary Online Content 1 Supplementary Online Content Friedman DJ, Piccini JP, Wang T, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery

More information

Complications of Diabetes: Screening and Prevention

Complications of Diabetes: Screening and Prevention Complications of Diabetes: Screening and Prevention Dr Steve Cleland Consultant Physician GGH and QEUH Diabetes Staff Education Course June 17 Diabetic Complications Microvascular: Retinopathy Nephropathy

More information

Introduction ARTICLE. and 3.4%, respectively. In both the medium- and majorweight-reduction

Introduction ARTICLE. and 3.4%, respectively. In both the medium- and majorweight-reduction Diabetologia (2015) 58:1448 1453 DOI 10.1007/s00125-015-3591-y ARTICLE Incidence and remission of type 2 diabetes in relation to degree of obesity at baseline and 2 year weight change: the Swedish Obese

More information

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart. Supplementary Figure S1. Cohort definition flow chart. Supplementary Table S1. Baseline characteristics of study population grouped according to having developed incident CKD during the follow-up or not

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Xu X, Qin X, Li Y, et al. Efficacy of folic acid therapy on the progression of chronic kidney disease: the Renal Substudy of the China Stroke Primary Prevention Trial. JAMA

More information

30% of patients with T2D have high levels of urine albumin at diagnosis: 75% MAU 25% overt diabetic nephropathy

30% of patients with T2D have high levels of urine albumin at diagnosis: 75% MAU 25% overt diabetic nephropathy Identifying Patients with Type 2 Diabetes at High Risk of Microalbuminuria: the DEMAND (Developing Education on Microalbuminuria for Awareness of renal and cardiovascular risk in Diabetes) Study. Rossi

More information

OBESITY 2008: DIET, EXERCISE, DRUGS, AND SURGERY

OBESITY 2008: DIET, EXERCISE, DRUGS, AND SURGERY OBESITY 2008: DIET, EXERCISE, DRUGS, AND SURGERY Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest CLASSIFICATION OF OVERWEIGHT

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Irish AB, Viecelli AK, Hawley CM, et al; for the Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group.

More information

4. resisted training ** OR resistance training * OR resisted exercise ** OR resistance exercise ** OR strength training ** OR strength exercise **

4. resisted training ** OR resistance training * OR resisted exercise ** OR resistance exercise ** OR strength training ** OR strength exercise ** Supplementary Table 1. Search strategy (up to January 10 th 2015). MEDLINE Result: 253 studies 1. clinical trial ** OR controlled trial ** OR randomized controlled trial * OR randomised controlled trial

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova N. Trends in infective endocarditis in California and New York State, 1998-2013. JAMA. doi:10.1001/jama.2017.4287

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Basaria S, Harman SM, Travison TG, et al. The effects of testosterone administration for three years on subclinical atherosclerosis progression in older men with low or low

More information

Lucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1*

Lucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1* Cea Soriano et al. Cardiovascular Diabetology (2015) 14:38 DOI 10.1186/s12933-015-0204-5 CARDIO VASCULAR DIABETOLOGY ORIGINAL INVESTIGATION Open Access Cardiovascular events and all-cause mortality in

More information

Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology

Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology Disclosures In compliance with the accrediting board policies, the American Diabetes Association requires the

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Inohara T, Xian Y, Liang L, et al. Association of intracerebral hemorrhage among patients taking non vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital

More information

Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).

Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416). Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52

More information

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

Central pressures and prediction of cardiovascular events in erectile dysfunction patients Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,

More information

Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus

Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus A Fib & Flutter I48.0 Paroxysmal atrial fibrillation I48.1 Persistent atrial fibrillation I48.2 Chronic atrial fibrillation I48.3 Typical atrial flutter Asthma J45.20 Mild, uncomplicated J45.21 Mild, with

More information

Cardiovascular Diabetology. Open Access ORIGINAL INVESTIGATION. C. R. L. Cardoso 1, N. C. Leite 1, C. B. M. Moram 2 and G. F.

Cardiovascular Diabetology. Open Access ORIGINAL INVESTIGATION. C. R. L. Cardoso 1, N. C. Leite 1, C. B. M. Moram 2 and G. F. https://doi.org/10.1186/s12933-018-0677-0 Cardiovascular Diabetology ORIGINAL INVESTIGATION Open Access Long term visit to visit glycemic variability as predictor of micro and macrovascular complications

More information

The Burden of the Diabetic Heart

The Burden of the Diabetic Heart The Burden of the Diabetic Heart Dr. Ghaida Kaddaha (MBBS, MRCP-UK, FRCP-london) Diabetes Unit Rashid Hospital Dubai U.A.E Risk of CVD in Diabetes Morbidity and mortality from CVD is 2-4 fold higher than

More information

Treating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition

Treating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition Treating Type 2 Diabetes by Treating Obesity Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition 2 Center Stage Obesity is currently an epidemic in the United States, with

More information

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental

More information

FY 2011 WISEWOMAN Approved ICD-9 Code List

FY 2011 WISEWOMAN Approved ICD-9 Code List 243 Congenital hypothyroidism 245.0 Thyroiditis; Acute thyroiditis 245.1 Thyroiditis; Subacute thyroiditis 245.2 Thyroiditis; Chronic lymphocytic thyroiditis 245.3 Thyroiditis; Chronic fibrous thyroiditis

More information

Quality of prescribing in chronic kidney disease and type 2 diabetes Smits, Kirsten Petronella Juliana

Quality of prescribing in chronic kidney disease and type 2 diabetes Smits, Kirsten Petronella Juliana University of Groningen Quality of prescribing in chronic kidney disease and type 2 diabetes Smits, Kirsten Petronella Juliana IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Li S, Chiuve SE, Flint A, et al. Better diet quality and decreased mortality among myocardial infarction survivors. JAMA Intern Med. Published online September 2, 2013. doi:10.1001/jamainternmed.2013.9768.

More information

Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study

Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study Conflict of interest disclosure None Committee of Scientific Affairs Committee

More information

Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture

Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture Technical Appendix Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture and Associated Surgical Treatment ICD 9 Code Descriptions Hip Fracture 820.XX Fracture neck of femur 821.XX

More information

Clinical Practice Guideline Key Points

Clinical Practice Guideline Key Points Clinical Practice Guideline Key Points Clinical Practice Guideline 2008 Key Points Diabetes Mellitus Provided by: Highmark Endocrinology Clinical Quality Improvement Committee In accordance with Highmark

More information

DIABETES MEASURES GROUP OVERVIEW

DIABETES MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: DIABETES MEASURES GROUP OVERVIEW 2014 PQRS MEASURES IN DIABETES MEASURES GROUP: #1. Diabetes: Hemoglobin A1c Poor Control #2. Diabetes: Low Density Lipoprotein (LDL-C)

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney

More information

Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications

Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications Research Original Investigation Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications Lars Sjöström, MD, PhD; Markku Peltonen,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Schulz Schüpke S, Helde S, Gewalt S; et al. Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Guimarães PO, Krishnamoorthy A, Kaltenbach LA, et al. Accuracy of medical claims for identifying cardiovascular and bleeding events after myocardial infarction: a secondary

More information

Introduction. Keywords: Infrainguinal bypass; Prognosis; Haemorrhage; Anticoagulants; Antiplatelets.

Introduction. Keywords: Infrainguinal bypass; Prognosis; Haemorrhage; Anticoagulants; Antiplatelets. Eur J Vasc Endovasc Surg 30, 154 159 (2005) doi:10.1016/j.ejvs.2005.03.005, available online at http://www.sciencedirect.com on Risk of Major Haemorrhage in Patients after Infrainguinal Venous Bypass Surgery:

More information

LEADER Liraglutide and cardiovascular outcomes in type 2 diabetes

LEADER Liraglutide and cardiovascular outcomes in type 2 diabetes LEADER Liraglutide and cardiovascular outcomes in type 2 diabetes Presented at DSBS seminar on mediation analysis August 18 th Søren Rasmussen, Novo Nordisk. LEADER CV outcome study To determine the effect

More information

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator

More information

2013 Hypertension Measure Group Patient Visit Form

2013 Hypertension Measure Group Patient Visit Form Please complete the form below for 20 or more unique patients meeting patient sample criteria for the measure group for the current reporting year. A majority (11 or more) patients must be Medicare Part

More information

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):

More information

T. Suithichaiyakul Cardiomed Chula

T. Suithichaiyakul Cardiomed Chula T. Suithichaiyakul Cardiomed Chula The cardiovascular (CV) continuum: role of risk factors Endothelial Dysfunction Atherosclerosis and left ventricular hypertrophy Myocardial infarction & stroke Endothelial

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Clark WF, Sontrop JM, Huang S-H et al. Effect of Coaching to Increase Water Intake on Kidney Function Decline in Adults With Chronic Kidney Disease: the CKD WIT Randomized

More information

DR as a Biomarker for Systemic Vascular Complications

DR as a Biomarker for Systemic Vascular Complications DR as a Biomarker for Systemic Vascular Complications Lihteh Wu MD Asociados de Mácula, Vítreo y Retina de Costa Rica San José, Costa Rica LW65@cornell.edu Disclosures Dr Wu has received lecture fees from

More information

The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009

The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009 The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009 Learning Objectives 1. Understand the role of statin therapy in the primary and secondary prevention of stroke 2. Explain

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Shah AD, Langenberg C, Rapsomaniki E, et al.

More information

Microvascular Disease in Type 1 Diabetes

Microvascular Disease in Type 1 Diabetes Microvascular Disease in Type 1 Diabetes Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of Miami Miller School of Medicine The Course

More information

Cardiovascular Management of a Patient with Diabetes

Cardiovascular Management of a Patient with Diabetes Cardiovascular Management of a Patient with Diabetes Dr Jeremy Krebs Clinical Leader Endocrinology and Diabetes Wellington Hospital Summary People with diabetes take a lot of medication Compliance and

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content James MT, Neesh P, Hemmelgarn BR, et al. Derivation and external validation of prediction models for advanced chronic kidney disease following acute kidney injury. JAMA. doi:10.1001/jama.2017.16326

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study Synopsis for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the

More information

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group Primary and Secondary Prevention of Cardiovascular Disease Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group AHA Diet and Lifestyle Recommendations Balance calorie intake and physical activity to

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Anagnostou E, Aman MG, Handen BL, et al. Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autistic spectrum disorder:

More information

Data Analysis Plan for assessing clinical efficacy and safety of ER niacin/laropiprant in the HPS2-THRIVE trial

Data Analysis Plan for assessing clinical efficacy and safety of ER niacin/laropiprant in the HPS2-THRIVE trial Data Analysis Plan for assessing clinical efficacy and safety of ER niacin/laropiprant in the HPS2-THRIVE trial 1 Background This Data Analysis Plan describes the strategy, rationale and statistical methods

More information

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures

More information

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are page 1 Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association.

More information

Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese

Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Diabetes Care Publish Ahead of Print, published online June 12, 2008 Raised Blood Pressure and Dysglycemia Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Bernard My Cheung,

More information

Definitions of chronic conditions used to define the number of serious comorbidities in the study.

Definitions of chronic conditions used to define the number of serious comorbidities in the study. Supplementary Table 1 Definitions of chronic conditions used to define the number of serious comorbidities in the study. Comorbidity ICD-9 Code Description CAD/MI 410.x Acute myocardial infarction 411.x

More information

The Diabetes Link to Heart Disease

The Diabetes Link to Heart Disease The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM

More information

Statistical Fact Sheet Populations

Statistical Fact Sheet Populations Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total

More information

Comparability of patient-reported health status: multi-country analysis of EQ-5D responses in patients with type 2 diabetes

Comparability of patient-reported health status: multi-country analysis of EQ-5D responses in patients with type 2 diabetes Comparability of patient-reported health status: multi-country analysis of EQ-5D responses in patients with type 2 diabetes Joshua A Salomon, Anushka Patel, Bruce Neal, Paul Glasziou, Diederick E. Grobbee,

More information

Antihypertensive Trial Design ALLHAT

Antihypertensive Trial Design ALLHAT 1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes

More information

Standards of Medical Care in Diabetes 2016

Standards of Medical Care in Diabetes 2016 Standards of Medical Care in Diabetes 2016 Care Delivery Systems 33-49% of patients still do not meet targets for A1C, blood pressure, or lipids. 14% meet targets for all A1C, BP, lipids, and nonsmoking

More information

Low ALT Levels Independently Associated with 22-Year All-Cause Mortality Among Coronary Heart Disease Patients

Low ALT Levels Independently Associated with 22-Year All-Cause Mortality Among Coronary Heart Disease Patients Low ALT Levels Independently Associated with 22-Year All-Cause Mortality Among Coronary Heart Disease Patients N. Peltz-Sinvani, MD 1,4,R.Klempfner,MD 2,4, E. Ramaty, MD 1,4,B.A.Sela,PhD 3,4,I.Goldenberg,MD

More information

The Clinical Unmet need in the patient with Diabetes and ACS

The Clinical Unmet need in the patient with Diabetes and ACS The Clinical Unmet need in the patient with Diabetes and ACS Professor Kausik Ray (UK) BSc(hons), MBChB, MD, MPhil, FRCP (lon), FRCP (ed), FACC, FESC, FAHA Diabetes is a global public health challenge

More information

PROTEZIONE DAL DANNO RENALE NEL DIABETE TIPO 2: RUOLO DEI NUOVI FARMACI. Massimo Boemi UOC Malattie Metaboliche e Diabetologia IRCCS INRCA Ancona

PROTEZIONE DAL DANNO RENALE NEL DIABETE TIPO 2: RUOLO DEI NUOVI FARMACI. Massimo Boemi UOC Malattie Metaboliche e Diabetologia IRCCS INRCA Ancona PROTEZIONE DAL DANNO RENALE NEL DIABETE TIPO 2: RUOLO DEI NUOVI FARMACI Massimo Boemi UOC Malattie Metaboliche e Diabetologia IRCCS INRCA Ancona Disclosure Dr Massimo Boemi has been granted as speaker

More information

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria 1. Albuminuria an early sign of glomerular damage and renal disease albuminuria Cardio-renal continuum REGRESS Target organ damage Asymptomatic CKD New risk factors Atherosclerosis Target organ damage

More information

Contractor Information. LCD Information. Local Coverage Determination (LCD): HOMOCYSTeine Level, Serum (L34419) Document Information

Contractor Information. LCD Information. Local Coverage Determination (LCD): HOMOCYSTeine Level, Serum (L34419) Document Information Local Coverage Determination (LCD): HOMOCYSTeine Level, Serum (L34419) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor

More information

Adult Diabetes Clinician Guide NOVEMBER 2017

Adult Diabetes Clinician Guide NOVEMBER 2017 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Adult Diabetes Clinician Guide Introduction NOVEMBER 2017 This evidence-based guideline summary is based on the 2017 KP National Diabetes Guideline.

More information

Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease

Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease D. Dallmeier 1, D. Rothenbacher 2, W. Koenig 1, H. Brenner

More information

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±

More information

Diabetes Control and Complications in Public Hospitals in Malaysia

Diabetes Control and Complications in Public Hospitals in Malaysia ORIGINAL ARTICLE Diabetes Control and Complications in Public Hospitals in Malaysia Mafauzy M. FRCP For the Diabcare-Malaysia Study Group, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian,

More information

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,

More information

The Metabolic Syndrome: Is It A Valid Concept? YES

The Metabolic Syndrome: Is It A Valid Concept? YES The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA

More information

Heart Disease and Stroke Statistics 2010 Update. 2009, American Heart Association. All rights reserved.

Heart Disease and Stroke Statistics 2010 Update. 2009, American Heart Association. All rights reserved. Heart Disease and Stroke Statistics 21 Update Questions on statistics? mailto:nancy.haase@heart.org Audio-visual questions? mailto:david.brentz@heart.org Please keep the red wave and logo attached to these

More information

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Callaghan B, McCammon R, Kerber K, Xu X, Langa KM, Feldman E. Tests and expenditures in the initial evaluation of peripheral neuropathy. Arch Intern Med. 2012;172(2):127-132.

More information

Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan.

Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Manabu Izumi, Kazuo Suzuki, Tetsuya Sakamoto and Masato Hayashi Jichi Medical University

More information